1
|
Cui Y, Li J, Zheng F, Ouyang Y, Chen X, Zhang L, Chen Y, Wang L, Mu S, Zhang H. Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells. Med Sci Monit 2016; 22:380-6. [PMID: 26847404 PMCID: PMC4747318 DOI: 10.12659/msm.895312] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Background The epithelial-mesenchymal transition (EMT) has been shown to be involved in the process of invasion and metastasis of prostate cancer. SIRT1 is the mammalian homologue of the silent information regulator 2 (Sir2) gene, and is abnormally expressed in prostate cancer cells. Therefore, it is hypothesized that SIRT1 mediates the invasion/metastatic ability of prostate cancer via EMT regulation. This study thus investigated the effect of SIRT1 gene on the invasion and migration of prostate cancer cell line PC-3 via the small interference RNA (siRNA) against SIRT1. Material/Methods SiRNA construct was transfected into PC-3 cells, which were tested for the cell migration and invasion ability by scratch assay and Transwell migration assay, respectively. Expression levels of vimentin, E-cadherin, and N-cadherin were further quantified by Western blotting and RT-PCR. Results Both mRNA and protein levels of SIRT1 were depressed after siRNA transfection, along with weakened migration and invasion ability of PC-3 cells. Elevated E-cadherin and suppressed N-cadherin and vimentin were observed in those transfected cells. Conclusions The silencing of SIRT1 gene in PC-3 cells can suppress the movement, migration, and invasion functions of prostate cancer cells, possibly via the down-regulation of mesenchymal markers vimentin and N-cadherin accompanied with up-regulation of epithelial marker N-cadherin, thus reversing the EMT process.
Collapse
Affiliation(s)
- Ying Cui
- Department of Blood Transfusion, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi, China (mainland)
| | - Jiang Li
- Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi, China (mainland)
| | - Fei Zheng
- Department of Hepatobiliary Surgery, General Hospital of Shenyang Military Command, Shenyang, Liaoning, China (mainland)
| | - Yongri Ouyang
- Department of Medical Laboratory and Research Center, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi, China (mainland)
| | - Xi Chen
- Department of Medical Laboratory and Research Center, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi, China (mainland)
| | - Lei Zhang
- Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi, China (mainland)
| | - Yang Chen
- Department of Blood Transfusion, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi, China (mainland)
| | - Lin Wang
- Department of Blood Transfusion, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi, China (mainland)
| | - Shijie Mu
- Department of Blood Transfusion, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi, China (mainland)
| | - Huizhong Zhang
- Department of Medical Laboratory and Research Center, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shanxi, China (mainland)
| |
Collapse
|